FDA Adverse Event Malfunction Summary report: N

PRISM 6 CHANNEL ANALYZER

MDR report key: 5191277 · Received October 30, 2015

Report

Report Number
1628664-2015-00271
Event Type
Malfunction
Date Received
October 30, 2015
Date of Event
October 1, 2015
Report Date
December 23, 2015
Manufacturer
ABBOTT MANUFACTURING INC
Product Code
MZA
PMA / PMN Number
BK970042
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. AN EVALUATION IS IN-PROCESS.

Additional Manufacturer Narrative · 1

FURTHER EVALUATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, IN-HOUSE TESTING, A DESIGN HISTORY RECORD REVIEW, A SEARCH FOR SIMILAR COMPLAINTS, AND A REVIEW OF PRODUCT LABELING. RETURN MATERIAL WAS NOT AVAILABLE. A SPECIFICITY TESTING PROTOCOL WAS EXECUTED USING (B)(6), LIST NUMBER 7G46-48, LOT NUMBER 52851LI00 AND PRISM REACTION TRAYS,LIST NUMBER 5A07-01, LOT NUMBER 52082M500. TESTING MET THE ACCEPTANCE CRITERIA AND DETERMINED THE THE PRODUCT IS MEETING EXPECTED SPECIFICITY REQUIREMENTS AND ARE PERFORMING ACCEPTABLY. A DESIGN HISTORY REVIEW DID NOT FIND ANY ISSUES. TRACKING AND TRENDING DID NOT IDENTIFY AN ADVERSE TREND. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. BASED ON THE AVAILABLE INFORMATION NO PRODUCT DEFICIENCY OF THE A PRISM 6 CHANNEL ANALYZER, LIST NUMBER 06A36 WAS IDENTIFIED.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED (B)(6) RESULTS WHILE USING THE ABBOTT PRISM HIV AG/AB COMBO ASSAY AND THE PRISM REACTION TRAYS ON THE PRISM ANALYZER. THE CUSTOMER PROVIDED THE FOLLOWING RESULTS: INITIAL 3.23, RETESTS: 12.88 AND 0.10 S/CO. THE SPECIMEN WAS P24 AND (B)(6) WHEN TESTED USING THE GENIUS METHOD. THERE WAS NO ADVERSE IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
721835 PRISM 6 CHANNEL ANALYZER AUTOMATED IMMUNOASSAY ANALYZER MZA ABBOTT MANUFACTURING INC

Patients

Seq Age Sex Outcome Treatment
1